Genetic and molecular heterogeneity of breast cancer cells

Robert Callahan, Craig Cropp, Giorgio R. Merlo, Francesca Diella, Tiziana Venesio, Rosette Lidereau, Alberto P M Cappa, Daniel S. Lisicia

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We have undertaken a systematic study of primary human breast tumor DNAa to identify and characterize frequently occurring somatic mutations. Loss of heterozygosity (LOH) was found on chromosomes 1p (37%), 1q (20%), 3p (30%), 7 (41%), 13q (30%), 17p (49%) and 18q (34%) in our tumor DNA panel. Specific subsets of tumors could be defined based on the particular collection of mutations they contained. One goal of these studies has been to determine whether there is a significant association between specific mutations and clinical parameters of the disease. We have found that LOH on chromosome 17p in tumor DNAs is associated with breast tumors having a high proliferative index and that LOH on chromosome 7 is associated with patients having a poor prognosis. Our analysis of chromosome 17 suggests that there may be as many as four tumor suppressor genes affected in primary human breast tumors.

Original languageEnglish
Pages (from-to)63-73
Number of pages11
JournalClinica Chimica Acta
Volume217
Issue number1
DOIs
Publication statusPublished - Jul 30 1993

Fingerprint

Genetic Heterogeneity
Loss of Heterozygosity
Tumors
Cells
Breast Neoplasms
Mutation
Chromosomes
Neoplasms
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 7
DNA
Tumor Suppressor Genes
Genes

Keywords

  • Breast cancer
  • Mutations P53 gene
  • NM23 gene

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Callahan, R., Cropp, C., Merlo, G. R., Diella, F., Venesio, T., Lidereau, R., ... Lisicia, D. S. (1993). Genetic and molecular heterogeneity of breast cancer cells. Clinica Chimica Acta, 217(1), 63-73. https://doi.org/10.1016/0009-8981(93)90238-Y

Genetic and molecular heterogeneity of breast cancer cells. / Callahan, Robert; Cropp, Craig; Merlo, Giorgio R.; Diella, Francesca; Venesio, Tiziana; Lidereau, Rosette; Cappa, Alberto P M; Lisicia, Daniel S.

In: Clinica Chimica Acta, Vol. 217, No. 1, 30.07.1993, p. 63-73.

Research output: Contribution to journalArticle

Callahan, R, Cropp, C, Merlo, GR, Diella, F, Venesio, T, Lidereau, R, Cappa, APM & Lisicia, DS 1993, 'Genetic and molecular heterogeneity of breast cancer cells', Clinica Chimica Acta, vol. 217, no. 1, pp. 63-73. https://doi.org/10.1016/0009-8981(93)90238-Y
Callahan R, Cropp C, Merlo GR, Diella F, Venesio T, Lidereau R et al. Genetic and molecular heterogeneity of breast cancer cells. Clinica Chimica Acta. 1993 Jul 30;217(1):63-73. https://doi.org/10.1016/0009-8981(93)90238-Y
Callahan, Robert ; Cropp, Craig ; Merlo, Giorgio R. ; Diella, Francesca ; Venesio, Tiziana ; Lidereau, Rosette ; Cappa, Alberto P M ; Lisicia, Daniel S. / Genetic and molecular heterogeneity of breast cancer cells. In: Clinica Chimica Acta. 1993 ; Vol. 217, No. 1. pp. 63-73.
@article{010b1b91aa8a4403b0fabee9d53529ab,
title = "Genetic and molecular heterogeneity of breast cancer cells",
abstract = "We have undertaken a systematic study of primary human breast tumor DNAa to identify and characterize frequently occurring somatic mutations. Loss of heterozygosity (LOH) was found on chromosomes 1p (37{\%}), 1q (20{\%}), 3p (30{\%}), 7 (41{\%}), 13q (30{\%}), 17p (49{\%}) and 18q (34{\%}) in our tumor DNA panel. Specific subsets of tumors could be defined based on the particular collection of mutations they contained. One goal of these studies has been to determine whether there is a significant association between specific mutations and clinical parameters of the disease. We have found that LOH on chromosome 17p in tumor DNAs is associated with breast tumors having a high proliferative index and that LOH on chromosome 7 is associated with patients having a poor prognosis. Our analysis of chromosome 17 suggests that there may be as many as four tumor suppressor genes affected in primary human breast tumors.",
keywords = "Breast cancer, Mutations P53 gene, NM23 gene",
author = "Robert Callahan and Craig Cropp and Merlo, {Giorgio R.} and Francesca Diella and Tiziana Venesio and Rosette Lidereau and Cappa, {Alberto P M} and Lisicia, {Daniel S.}",
year = "1993",
month = "7",
day = "30",
doi = "10.1016/0009-8981(93)90238-Y",
language = "English",
volume = "217",
pages = "63--73",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Genetic and molecular heterogeneity of breast cancer cells

AU - Callahan, Robert

AU - Cropp, Craig

AU - Merlo, Giorgio R.

AU - Diella, Francesca

AU - Venesio, Tiziana

AU - Lidereau, Rosette

AU - Cappa, Alberto P M

AU - Lisicia, Daniel S.

PY - 1993/7/30

Y1 - 1993/7/30

N2 - We have undertaken a systematic study of primary human breast tumor DNAa to identify and characterize frequently occurring somatic mutations. Loss of heterozygosity (LOH) was found on chromosomes 1p (37%), 1q (20%), 3p (30%), 7 (41%), 13q (30%), 17p (49%) and 18q (34%) in our tumor DNA panel. Specific subsets of tumors could be defined based on the particular collection of mutations they contained. One goal of these studies has been to determine whether there is a significant association between specific mutations and clinical parameters of the disease. We have found that LOH on chromosome 17p in tumor DNAs is associated with breast tumors having a high proliferative index and that LOH on chromosome 7 is associated with patients having a poor prognosis. Our analysis of chromosome 17 suggests that there may be as many as four tumor suppressor genes affected in primary human breast tumors.

AB - We have undertaken a systematic study of primary human breast tumor DNAa to identify and characterize frequently occurring somatic mutations. Loss of heterozygosity (LOH) was found on chromosomes 1p (37%), 1q (20%), 3p (30%), 7 (41%), 13q (30%), 17p (49%) and 18q (34%) in our tumor DNA panel. Specific subsets of tumors could be defined based on the particular collection of mutations they contained. One goal of these studies has been to determine whether there is a significant association between specific mutations and clinical parameters of the disease. We have found that LOH on chromosome 17p in tumor DNAs is associated with breast tumors having a high proliferative index and that LOH on chromosome 7 is associated with patients having a poor prognosis. Our analysis of chromosome 17 suggests that there may be as many as four tumor suppressor genes affected in primary human breast tumors.

KW - Breast cancer

KW - Mutations P53 gene

KW - NM23 gene

UR - http://www.scopus.com/inward/record.url?scp=0027281587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027281587&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(93)90238-Y

DO - 10.1016/0009-8981(93)90238-Y

M3 - Article

C2 - 8222284

AN - SCOPUS:0027281587

VL - 217

SP - 63

EP - 73

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1

ER -